ReviewFrontiers in pharmacology2021

Impact of Dose Reduction of Afatinib Used in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Ziyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.